Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Dr. Reddy's Laboratories submits press release
Date: 16-09-2019Dr. Reddy's Laboratories has informed about submission of a Press Release on ‘Dr. Reddy's announces the launch of over-the-counter, store-brand equivalent of Prevacid 24HR Capsules (Lansoprazole Delayed-Release Capsules USP, 15 mg) in the US Market’.
The above information is a part of company’s filings submitted to BSE.